GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice ...

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious ...